Mozarc Medical is proud to partner with DK Medtech to bring new PTA balloon technology to the U.S. AV access market.
Innovative balloon technology partnership poised to elevate U.S. dialysis vascular access
Furthering a commitment to patient-centric options in kidney health innovation, Mozarc Medical today announced the kick-off of a strategic collaboration with DK Medical Technology (Suzhou) Co., Ltd. (DK Medtech) in the United States.
Jointly addressing clinical challenges faced by kidney disease patients during dialysis, Mozarc Medical will now exclusively distribute DK Medtech’s DKutting™* PTA Scoring Balloon Dilatation Catheter and DKaptain™* PTA High Pressure Balloon Dilatation Catheter in the U.S. — supporting the advancement of clinical therapies in dialysis vascular access management.
Ven Manda, CEO of Mozarc Medical: “Our partnership with DK Medtech could benefit more than 500,000 American dialysis patients.1 The addition of DKutting and DKaptain strengthen our Renal Access therapies. Together we are working to improve options for dialysis patients’ AV fistula maintenance.”
Yulin Weng, Founder & CEO of DK Medtech: “Partnering with Mozarc Medical is a landmark in DK Medtech’s global journey. Our decade-long dedication to original technologies delivers an answer to specialized vascular balloons.”
DKutting™* PTA Scoring Balloon Dilatation Catheter:
This balloon catheter combines directional scoring and high-pressure expansion. Its patented nitinol coiled wire scoring design enables precise, controlled dilation of high resistant stenoses in tortuous anastomotic sites, minimizing vessel trauma.2-4
DKaptain™* PTA High Pressure Balloon Dilatation Catheter:
Engineered for complex lesions, the catheter can manage burst pressure of up to 26 atm and accommodate vessel diameters from 4.0mm to 12.0mm, covering full-range clinical needs for vascular access.5
About Mozarc Medical:
Mozarc Medical is a DaVita and Medtronic joint-venture company headquartered in Minneapolis, MN (U.S.). A global pioneer in kidney health solutions and leader in AV access in the U.S., Mozarc Medical is committed to bringing patient-centric innovation to the field of dialysis, focusing on transformative kidney health therapies, including dialysis access, and pediatric care devices.
About DK Medtech:
DK Medical Technology (Suzhou) Co., Ltd. (DK Medtech), a leading Chinese innovator in interventional balloon technologies, founded in 2015 and headquartered in Suzhou, China. DK Medtech is committed to improving patient lives through innovative coronary, peripheral, neurovascular, and dialysis interventions, with a focus on interventional balloon technologies (e.g., scoring, drug-coated, and high-pressure balloons).
DKaptain™* PTA high pressure balloon catheter
DKutting™* PTA scoring balloon catheter
Explore our full line of options
From access through treatment – Learn more about the unique benefits of our full product line for the United States.
- Kidney Disease Statistics for the United States, National Institute for Health, 2024
- Internal test report – Design verification for PTA scoring balloon dilatation catheter – compliance test, DKutting (control and application). DK Medical Technology Co., Ltd; Data on File.
- Internal test report – PTA scoring balloon tortuous vessel performance comparisons. DKutting. DK Medical Technology Co., Ltd; Data on File (Data based on simulation model).
- Internal test report – PTA Scoring balloon clinical evaluation and vessel trauma comparisons, DKutting. DK Medical Technology Co., Ltd; Data on File.
- Internal test report – Lesion access performance, DKaptain. DK Medical Technology Co., Ltd; Data on File.
DKutting is a product of DK MedTech and sold under distribution partnership with Mozarc Medical. All claims and references are certified for U.S. standards accuracy and use by DK MedTech.